This story has been updated to include comments made by NantHealth management during a conference call.

CHICAGO (GenomeWeb) — NantHealth’s revenues for the third quarter increased by 5 percent year over year, the company said after the markets closed on Thursday.

For the three months ended Sept. 30, the Culver City, California-based firm posted revenues of  $21.8 million, up from $20.7 million in the same period a year earlier. It missed the consensus Wall Street estimate of $29.2 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.